2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG DOI Open Access
Robert A. Byrne, Stephen E. Fremes, Davide Capodanno

et al.

European Heart Journal, Journal Year: 2023, Volume and Issue: 44(41), P. 4310 - 4320

Published: Aug. 26, 2023

Abstract In October 2021, the European Society of Cardiology (ESC) and Association for Cardio-Thoracic Surgery (EACTS) jointly agreed to establish a Task Force (TF) review recommendations 2018 ESC/EACTS Guidelines on myocardial revascularization as they apply patients with left main (LM) disease low-to-intermediate SYNTAX score (0–32). This followed withdrawal support by EACTS in 2019 about management LM previous guideline. The TF was asked all new relevant data since guidelines including updated aggregated from four randomized trials comparing percutaneous coronary intervention (PCI) drug-eluting stents vs. artery bypass grafting (CABG) disease. document represents summary work TF; suggested choice modality undergoing are included. stable an indication disease, anatomy suitable both procedures low predicted surgical mortality, concludes that treatment options clinically reasonable based patient preference, available expertise, local operator volumes. CABG Class I, Level Evidence A. PCI IIa, recognized several important gaps knowledge related recognizes were still only large enough exclude differences mortality.

Language: Английский

Heart Disease and Stroke Statistics—2021 Update DOI Creative Commons
Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio

et al.

Circulation, Journal Year: 2021, Volume and Issue: 143(8)

Published: Jan. 27, 2021

The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders, subclinical atherosclerosis, coronary failure, valvular venous peripheral artery disease) associated outcomes quality care, procedures, economic costs).The through its Statistics Committee, continuously monitors evaluates sources stroke United States provide current information available annual Update. 2021 is product full year's worth effort by dedicated volunteer clinicians scientists, committed government professionals, Association staff members. This edition includes monitoring benefits population, an enhanced focus social determinants health, adverse pregnancy outcomes, vascular contributions brain global burden further evidence-based approaches changing disease.Each 27 chapters focuses different topic statistics.The represents critical resource for lay public, policy makers, media clinicians, care administrators, researchers, advocates, others seeking best these conditions.

Language: Английский

Citations

4712
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association DOI Creative Commons

Connie W. Tsao,

Aaron W. Aday, Zaid Almarzooq

et al.

Circulation, Journal Year: 2022, Volume and Issue: 145(8)

Published: Jan. 26, 2022

The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders, subclinical atherosclerosis, coronary failure, valvular venous peripheral artery disease) associated outcomes quality care, procedures, economic costs).

Language: Английский

Citations

4265
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association DOI Creative Commons

Connie W. Tsao,

Aaron W. Aday, Zaid Almarzooq

et al.

Circulation, Journal Year: 2023, Volume and Issue: 147(8)

Published: Jan. 25, 2023

Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders, subclinical atherosclerosis, coronary failure, valvular venous peripheral artery disease) associated outcomes quality care, procedures, economic costs). Methods: through its Epidemiology Prevention Statistics Committee, continuously monitors evaluates sources stroke United States provide current information available annual review published literature year before writing. 2023 is product full year’s worth effort 2022 by dedicated volunteer clinicians scientists, committed government professionals, Association staff members. strives further understand help heal problems inflicted structural racism, public crisis can significantly damage mental perpetuate disparities access education, income, housing, several other vital healthy lives. This edition includes additional COVID-19 (coronavirus 2019) publications, as well monitoring benefits population, an enhanced focus equity across key domains. Results: Each chapters focuses different topic statistics. Conclusions: represents critical resource for lay public, policymakers, media clinicians, care administrators, researchers, advocates, others seeking best these conditions.

Language: Английский

Citations

4232
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization DOI Creative Commons

Jennifer S. Lawton,

Jacqueline E. Tamis-Holland,

Sripal Bangalore

et al.

Journal of the American College of Cardiology, Journal Year: 2021, Volume and Issue: 79(2), P. e21 - e129

Published: Dec. 9, 2021

Language: Английский

Citations

989
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association DOI Creative Commons
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq

et al.

Circulation, Journal Year: 2024, Volume and Issue: 149(8)

Published: Jan. 24, 2024

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, obesity) factors (cholesterol, blood pressure, glucose control, metabolic syndrome) that contribute health. AHA Disease Stroke Statistical Update presents latest data on a range major clinical circulatory disease conditions (including brain health, complications pregnancy, kidney congenital rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary cardiomyopathy, failure, valvular venous thromboembolism, peripheral artery disease) associated outcomes quality care, procedures, economic costs). METHODS: AHA, through its Epidemiology Prevention Statistics Committee, continuously monitors evaluates sources stroke United States globally provide current information available annual review published literature year before writing. 2024 is product full year’s worth effort 2023 by dedicated volunteer clinicians scientists, committed government professionals, staff members. strives further understand help heal problems inflicted structural racism, public crisis can significantly damage mental perpetuate disparities access education, income, housing, several other vital healthy lives. This edition includes additional global data, as well monitoring benefits population, an enhanced focus equity across key domains. RESULTS: Each chapters focuses different topic statistics. CONCLUSIONS: represents critical resource for lay public, policymakers, media clinicians, care administrators, researchers, advocates, others seeking best these conditions.

Language: Английский

Citations

914
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines DOI Open Access

Jennifer S. Lawton,

Jacqueline E. Tamis‐Holland, Sripal Bangalore

et al.

Circulation, Journal Year: 2021, Volume and Issue: 145(3)

Published: Dec. 9, 2021

Language: Английский

Citations

869
2024 ESC Guidelines for the management of chronic coronary syndromes DOI Creative Commons
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas

et al.

European Heart Journal, Journal Year: 2024, Volume and Issue: 45(36), P. 3415 - 3537

Published: Aug. 30, 2024

Language: Английский

Citations

477
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial DOI
Niels Ramsing Holm, Timo H. Mäkikallio, Mitchell Lindsay

et al.

The Lancet, Journal Year: 2019, Volume and Issue: 395(10219), P. 191 - 199

Published: Dec. 23, 2019

Language: Английский

Citations

368
Percutaneous coronary intervention for bifurcation coronary lesions: the 15<sup>th</sup> consensus document from the European Bifurcation Club DOI
Francesco Burzotta, Jens Flensted Lassen, Thierry Lefévre

et al.

EuroIntervention, Journal Year: 2021, Volume and Issue: 16(16), P. 1307 - 1317

Published: March 1, 2021

The 15th European Bifurcation Club (EBC) meeting was held in Barcelona October 2019. It facilitated a renewed consensus on coronary bifurcation lesions (CBL) and unprotected left main (LM) percutaneous interventions. stenting techniques continue to be refined, developed tested. remains evident that provisional approach with optional side branch treatment utilising T, T small protrusion (TAP) or culotte continues provide flexible options for the majority of CBL patients. Debate persists regarding optimal branches, including assessment clinical significance thresholds bail-out treatment. In more complex CBL, especially those involving LM, adoption dedicated two-stent should considered. Operators using such have fully familiar their procedural steps acknowledge associated limitations challenges. When techniques, failure perform final kissing inflation is regarded as technical failure, since it may jeopardise outcome. development novel tools drug regimens deserves attention. particular, intracoronary imaging, simulation, drug-eluting balloon technology tailored antiplatelet therapy been identified promising enhance outcomes. conclusion, evolution broad spectrum PCI components has resulted from studies extending bench testing randomised controlled trials. However, further advances are still needed achieve ambitious goal optimising outcomes every patient undergoing CBL.

Language: Английский

Citations

193
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis DOI
Marc S. Sabatine, Brian A. Bergmark, Sabina A. Murphy

et al.

The Lancet, Journal Year: 2021, Volume and Issue: 398(10318), P. 2247 - 2257

Published: Nov. 15, 2021

Language: Английский

Citations

190